Acetyl tetrapeptide-5
is used in cosmetic eye formulations to decrease puffiness, eye bags, and dark circles by reducing edema and protecting proteins such as SOD from glycation
Alanine
Ala / A · hydrophobic residue · neutral charge
AOD-9604
is studied as an anti-obesity peptide that can reduce weight gain and increase fat oxidation in obese animal models with generally neutral effects on IGF-1 and glucose metabolism in early human trials
Arginine
Arg / R · basic residue · positive charge
Argireline
is a topical cosmetic peptide reported to decrease dynamic wrinkles by partially mimicking the mechanism of botulinum toxin in a non-invasive manner
Asparagine
Asn / N · polar residue · neutral charge
Aspartic acid
Asp / D · acidic residue · negative charge
BPC-157
is investigated for accelerating healing of gastrointestinal mucosa, tendons, ligaments, bone, and nervous tissue in preclinical models, with anti-inflammatory and pro-angiogenic effects
Comparison
While Argireline is a topical cosmetic peptide reported to decrease dynamic wrinkles by partially mimicking the mechanism of botulinum toxin in a non-invasive manner49, Retatrutide is an investigational agent that produces very large body-weight reductions in early trials by simultaneously engaging GLP-1R, GIPR, and GCGR to enhance satiety, energy expenditure, and glycemic control2575.
While Argireline works as acetyl hexapeptide-8 (Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2), a SNAP-25–mimetic peptide that competitively inhibits SNARE complex assembly, reducing acetylcholine release at neuromuscular junctions and attenuating facial muscle contraction4959, Retatrutide is a triple incretin agonist peptide derived from a GIP backbone and engineered to activate GLP-1, GIP, and glucagon receptors, with non-natural residues and fatty-acid conjugation that confer long half-life and balanced multi-receptor signaling256575.
Argireline
Not assigned in the current dataset.
Retatrutide
Not assigned in the current dataset.
Argireline and Retatrutide are noticeably different, with limited direct overlap in their usual biological context. Their typical research and application settings separate fairly clearly: Argireline is more often discussed in the realm of Dermatology and aesthetics, whereas Retatrutide is more often associated with the realm of Metabolic and endocrine. They also influence different molecular systems, with Argireline tracking more closely to SNARE complex while Retatrutide centers more on GLP-1 receptor. Argireline has a more synthetic design origin, while Retatrutide is closer to synthetic analog background and their development context also differs, with Argireline cosmetic grade while Retatrutide is in Clinical phase 3. Argireline takes the form of a linear peptide, whereas Retatrutide is closer to a peptide conjugate, Argireline carries acetylation features, while Retatrutide instead reflects lipidation changes; while their sequence patterns also diverge, with Argireline showing protein-mimetic sequence features and Retatrutide showing alpha-helical domain features.